Brief: Chimeric Therapeutics Announces A$5 Million Placement
21/10/2024 01:50
Oct 21 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* A$5 MILLION PLACEMENT TO PROGRESS CHM CDH17 TRIAL
* PLACEMENT AT AN ISSUE PRICE OF A$0.008 PER NEW FULLY PAID
ORDINARY SHARE
* EXECUTIVE CHAIRMAN PAUL HOPPER TO PARTICIPATE WITH A$1
MILLION
INVESTMENT
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial